Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 21, 2004Clinical Infectious DiseasesOpen Access

Antimicrobial Resistance to Linezolid

View Full Paper
Ask AI
Bookmark
Share

Authors

VMVenkata G. MekaAstraZeneca (United States)HGHoward S. GoldBeth Israel Deaconess Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Meka et al. (2004) studied this question.

synapsesocial.com/papers/6a731263d5fcd090821d3229https://doi.org/10.1086/423841
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ribosomal and non‐ribosomal resistance to oxazolidinones: species‐specific idiosyncrasy of ribosomal alterations2002 · 94 citations
  2. 2Linezolid: The First Oxazolidinone Antimicrobial2003 · 328 citations
  3. 3Linezolid Resistance since 2001: SENTRY Antimicrobial Surveillance Program2003 · 153 citations
  4. 4Linezolid Resistance inStaphylococcus aureus:Characterization and Stability of Resistant Phenotype2002 · 195 citations
  5. 5Linezolid: The First Oxazolidinone Antimicrobial2003 · 463 citations